These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23598197)

  • 1. Study of Abl1 tyrosine kinase inhibitors by liquid chromatography-electrospray ionization-mass spectrometry.
    Chen H; Adams E; Van Schepdael A
    Talanta; 2013 Mar; 107():88-94. PubMed ID: 23598197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an indirect pulsed electrochemical detection method for monitoring the inhibition of Abl1 tyrosine kinase.
    Chen H; Wang X; Chopra S; Adams E; Van Schepdael A
    J Pharm Biomed Anal; 2014 Mar; 90():52-7. PubMed ID: 24333704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-ESI-MS method for the monitoring of Abl 1 tyrosine kinase.
    Chen H; Adams E; Van Schepdael A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():17-21. PubMed ID: 22538123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition.
    Simara P; Stejskal S; Koutna I; Potesil D; Tesarova L; Potesilova M; Zdrahal Z; Mayer J
    Am J Hematol; 2013 May; 88(5):385-93. PubMed ID: 23420553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Bali P; Estrella V; Kumaraswamy S; Rao R; Rocha K; Herger B; Lee F; Richon V; Bhalla K
    Clin Cancer Res; 2006 Oct; 12(19):5869-78. PubMed ID: 17020995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrochemical evaluation of Abelson tyrosine-protein kinase 1 activity and inhibition by imatinib mesylate and danusertib.
    Diculescu VC; Enache TA
    Anal Chim Acta; 2014 Oct; 845():23-9. PubMed ID: 25201268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MS.
    Iqbal Z; Elliott M; Watson DG; Holyoake T; Jørgensen H
    Pak J Pharm Sci; 2011 Jul; 24(3):285-91. PubMed ID: 21715261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy.
    Yeh CH; Abdool A; Bruey JM
    Cancer Biomark; 2010; 7(6):295-303. PubMed ID: 21694468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
    Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
    Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography-tandem mass spectrometry.
    Hou J; Qu F; Wu C; Ren Q; Zhang J
    J Pharm Biomed Anal; 2012 Jul; 66():232-9. PubMed ID: 22472186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important therapeutic targets in chronic myelogenous leukemia.
    Kantarjian HM; Giles F; Quintás-Cardama A; Cortes J
    Clin Cancer Res; 2007 Feb; 13(4):1089-97. PubMed ID: 17317816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential tyrosine phosphorylation of leukemic cells during apoptosis as a result of treatment with imatinib mesylate.
    Park J; Kim S; Oh C; Yoon SS; Lee D; Kim Y
    Biochem Biophys Res Commun; 2005 Oct; 336(3):942-51. PubMed ID: 16157305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of piperazine phosphate in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry employing precolumn derivatization with dansyl chloride.
    Lin H; Tian Y; Zhang Z; Wu L; Chen Y
    Anal Chim Acta; 2010 Apr; 664(1):40-8. PubMed ID: 20226930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML.
    Hentschel J; Rubio I; Eberhart M; Hipler C; Schiefner J; Schubert K; Loncarevic IF; Wittig U; Baniahmad A; von Eggeling F
    Int J Oncol; 2011 Sep; 39(3):585-91. PubMed ID: 21637917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 5-HT receptor antagonists, MEFWAY and MPPF using liquid chromatography electrospray ionization tandem mass spectrometry in rat plasma and brain tissue.
    Zheng Z; Lee BH; Choi JY; Ryu YH; Bae MA; Ahn SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():24-9. PubMed ID: 23266361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.
    An X; Tiwari AK; Sun Y; Ding PR; Ashby CR; Chen ZS
    Leuk Res; 2010 Oct; 34(10):1255-68. PubMed ID: 20537386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of erlotinib, gefitinib, and imatinib in human plasma by liquid chromatography tandem mass spectrometry.
    Chahbouni A; den Burger JC; Vos RM; Sinjewel A; Wilhelm AJ
    Ther Drug Monit; 2009 Dec; 31(6):683-7. PubMed ID: 19865001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma.
    Sparidans RW; Durmus S; Xu N; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():174-7. PubMed ID: 22476054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput liquid chromatography/electrospray ionization-tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma.
    Hirasawa T; Kikuchi M; Shigeta K; Takasaki S; Sato Y; Sato T; Ogura J; Onodera K; Fukuhara N; Onishi Y; Maekawa M; Mano N
    Biomed Chromatogr; 2021 Aug; 35(8):e5124. PubMed ID: 33772839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of rhein in human plasma by liquid chromatography-negative electrospray ionization tandem mass/mass spectrometry and the application in a pharmacokinetic study.
    Jiang JY; Yang MW; Qian W; Lin H; Geng Y; Zhou ZQ; Xiao DW
    J Pharm Biomed Anal; 2012 Jan; 57():19-25. PubMed ID: 21945452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.